Literature DB >> 32647587

Dissecting and rebuilding the glioblastoma microenvironment with engineered materials.

Kayla J Wolf1,2, Joseph Chen2, Jason Coombes2,3, Manish K Aghi4, Sanjay Kumar1,2,5.   

Abstract

Glioblastoma (GBM) is the most aggressive and common form of primary brain cancer. Several decades of research have provided great insight into GBM progression; however, the prognosis remains poor with a median patient survival time of ~ 15 months. The tumour microenvironment (TME) of GBM plays a crucial role in mediating tumour progression and thus is being explored as a therapeutic target. Progress in the development of treatments targeting the TME is currently limited by a lack of model systems that can accurately recreate the distinct extracellular matrix composition and anatomic features of the brain, such as the blood-brain barrier and axonal tracts. Biomaterials can be applied to develop synthetic models of the GBM TME to mimic physiological and pathophysiological features of the brain, including cellular and ECM composition, mechanical properties, and topography. In this Review, we summarize key features of the GBM microenvironment and discuss different strategies for the engineering of GBM TME models, including 2D and 3D models featuring chemical and mechanical gradients, interfaces and fluid flow. Finally, we highlight the potential of engineered TME models as platforms for mechanistic discovery and drug screening as well as preclinical testing and precision medicine.

Entities:  

Year:  2019        PMID: 32647587      PMCID: PMC7347297          DOI: 10.1038/s41578-019-0135-y

Source DB:  PubMed          Journal:  Nat Rev Mater        ISSN: 2058-8437            Impact factor:   66.308


  261 in total

1.  Preoperative and intraoperative diffusion tensor imaging-based fiber tracking in glioma surgery.

Authors:  Christopher Nimsky; Oliver Ganslandt; Peter Hastreiter; Ruopeng Wang; Thomas Benner; A Gregory Sorensen; Rudolf Fahlbusch
Journal:  Neurosurgery       Date:  2005       Impact factor: 4.654

2.  Microscale mechanisms of agarose-induced disruption of collagen remodeling.

Authors:  Theresa A Ulrich; Tae Geol Lee; Hyun Kyong Shon; Dae Won Moon; Sanjay Kumar
Journal:  Biomaterials       Date:  2011-05-14       Impact factor: 12.479

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling.

Authors:  Paula A Agudelo-Garcia; Jessica K De Jesus; Shante P Williams; Michal O Nowicki; Ennio Antonio Chiocca; Sandya Liyanarachchi; Pui-Kai Li; John J Lannutti; Jed K Johnson; Sean E Lawler; Mariano S Viapiano
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

Review 5.  Temozolomide: a milestone in neuro-oncology and beyond?

Authors:  Nicole Mutter; Roger Stupp
Journal:  Expert Rev Anticancer Ther       Date:  2006-08       Impact factor: 4.512

6.  Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity.

Authors:  V R Amberger; T Hensel; N Ogata; M E Schwab
Journal:  Cancer Res       Date:  1998-01-01       Impact factor: 12.701

7.  Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity.

Authors:  Reza Mirzaei; Susobhan Sarkar; Lauren Dzikowski; Khalil S Rawji; Lubaba Khan; Andreas Faissner; Pinaki Bose; V Wee Yong
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110

8.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 9.  AQ4N: a new approach to hypoxia-activated cancer chemotherapy.

Authors:  L H Patterson; S R McKeown
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  Engineering a Brain Cancer Chip for High-throughput Drug Screening.

Authors:  Yantao Fan; Duong Thanh Nguyen; Yasemin Akay; Feng Xu; Metin Akay
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

View more
  35 in total

1.  Collective invasion of glioma cells through OCT1 signalling and interaction with reactive astrocytes after surgery.

Authors:  Yangjin Kim; Donggu Lee; Sean Lawler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-07-27       Impact factor: 6.237

Review 2.  3D bioprinting of glioblastoma models.

Authors:  Carolina Parra-Cantu; Wanlu Li; Alfredo Quiñones-Hinojosa; Yu Shrike Zhang
Journal:  J 3D Print Med       Date:  2020-10-28

Review 3.  The multifaceted mechanisms of malignant glioblastoma progression and clinical implications.

Authors:  Rui Sun; Albert H Kim
Journal:  Cancer Metastasis Rev       Date:  2022-08-03       Impact factor: 9.237

4.  P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells.

Authors:  Pedro Vargas; Thamiris Becker Scheffel; Fernando Mendonça Diz; Liliana Rockenbach; Nathália Grave; Angélica Regina Cappellari; Luiza Wilges Kist; Maurício Reis Bogo; Marcos Paulo Thomé; Gabriel Fernandes Leal; Amanda de Fraga Dias; Fabrício Figueiró; Eduardo Cremonese Filippi-Chiela; Guido Lenz; Fernanda Bueno Morrone
Journal:  Purinergic Signal       Date:  2022-08-08       Impact factor: 3.950

Review 5.  Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity.

Authors:  Ryan C Gimple; Kailin Yang; Matthew E Halbert; Sameer Agnihotri; Jeremy N Rich
Journal:  Nat Rev Cancer       Date:  2022-06-16       Impact factor: 69.800

Review 6.  Application of 7T MRS to High-Grade Gliomas.

Authors:  L McCarthy; G Verma; G Hangel; A Neal; B A Moffat; J P Stockmann; O C Andronesi; P Balchandani; C G Hadjipanayis
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

Review 7.  Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier.

Authors:  Min Tang; Jeremy N Rich; Shaochen Chen
Journal:  Adv Mater       Date:  2020-12-16       Impact factor: 30.849

8.  The impact of initial tumor microenvironment on imaging phenotype.

Authors:  Tavarekere N Nagaraja; Ana C deCarvalho; Stephen L Brown; Brent Griffith; Katelynn Farmer; Susan Irtenkauf; Laura Hasselbach; Abir Mukherjee; Seamus Bartlett; O Grahm Valadie; Glauber Cabral; Robert A Knight; Ian Y Lee; George W Divine; James R Ewing
Journal:  Cancer Treat Res Commun       Date:  2021-01-19

Review 9.  Metabolic Drivers of Invasion in Glioblastoma.

Authors:  Joseph H Garcia; Saket Jain; Manish K Aghi
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 10.  Microphysiological systems to study tumor-stroma interactions in brain cancer.

Authors:  Edward R Neves; Brendan A C Harley; Sara Pedron
Journal:  Brain Res Bull       Date:  2021-06-21       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.